Canada is suspending the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it may be linked to rare blood clotsTORONTO -- Canada on Monday suspended the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it might be linked to rare blood clots. She said most of the patients in Europe who developed a rare blood clot after vaccination with AstraZeneca were women under age 55, and the fatality rate among those who develop clots is as high as 40%. Last week, the department changed its label on the vaccine to warn about the rare risk of blood clots. Canada is expected to receive 1.5 million doses of AstraZeneca from the U.S. on Wednesday. Canada has placed bigger bets on Pfizer and Moderna, ordering up to 76 million doses of Pfizer and up to 44 million of Moderna, compared with up to 20 million of AstraZeneca.

Source: ABC News March 29, 2021 17:47 UTC